# Multiple Ascending Dose Study of DW4421

> **NCT07691242** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Daewon Pharmaceutical Co., Ltd.** · enrollment: 56 (estimated)

## Conditions studied

- Healthy Adult Volunteers

## Interventions

- **DRUG:** DW4421S-T0
- **DRUG:** DW4421S-T2
- **DRUG:** DW4421S-T1
- **DRUG:** DW4421S-T3
- **DRUG:** DW4421S
- **DRUG:** DW4421-3

## Key facts

- **NCT ID:** NCT07691242
- **Lead sponsor:** Daewon Pharmaceutical Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2026-09
- **Primary completion:** 2026-12
- **Final completion:** 2027-02
- **Target enrollment:** 56 (ESTIMATED)
- **Last updated:** 2026-07-08


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07691242

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07691242, "Multiple Ascending Dose Study of DW4421". Retrieved via MORVS 2026-10-21 from https://api.morvs.ai/clinical/NCT07691242. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*